From owner-chemistry@ccl.net Sun May 5 12:30:00 2019 From: "Rene Thomsen rene.thomsen]*[molexus.io" To: CCL Subject: CCL: Molexus releases Molegro Virtual Docker 7.0 Message-Id: <-53724-190505121518-19836-T0rK61t7DLS6yztn/kUvsA-*-server.ccl.net> X-Original-From: "Rene Thomsen" Date: Sun, 5 May 2019 12:15:17 -0400 Sent to CCL by: "Rene Thomsen" [rene.thomsen|,|molexus.io] Aarhus, Denmark, May 5th, 2019 - Molexus is pleased to announce a new major release of Molegro Virtual Docker, an integrated platform for computational drug design available for Windows and Linux. Molegro Virtual Docker offers high-quality protein-ligand docking based on novel optimization techniques combined with a user interface experience focusing on usability and productivity. New features in version 7.0: * Support for Linux (64-bit). Ubuntu 16.04 and 18.04 are officially supported but other Linux distributions, such as CentOS 7, can be used as well. * New smooth shader-based molecular surfaces for improved visualization of molecules. * Import of SMILES molecules and generation of 3D ligand conformations using Balloon. * Minor user interface improvements and bug fixes. For more information, or to download a trial version, please visit our company website at: http://www.molexus.io or contact: Rene Thomsen, CEO Molexus E-mail: rene.thomsen]![molexus.io About Molexus Molexus is a Danish company developing novel high-quality drug discovery and data analysis software. Molexus is founded by the co-founders of Molegro and has acquired the commercial rights to distribute and continue development of Molegros flagship products: Molegro Virtual Docker and Molegro Data Modeller.